Charter Healthcare Group

Charter Healthcare Group concentrates on acquiring and operating hospice and post-acute care providers, primarily those serving Medicare beneficiaries. The firm targets regional agencies with established community referral networks and integrates them into a larger operational platform. The strategy is built around consolidating fragmented local providers to achieve scale in clinical oversight, compliance, and back-office functions. This reflects a broader private equity playbook in the hospice sector, where demographic trends support long-term demand growth.

Charter likely sources acquisitions through a combination of proprietary outreach to independent hospice founders and relationships with industry brokers specializing in healthcare services. In the hospice sector, many operators are local entrepreneurs nearing retirement without internal succession plans, creating a steady pipeline of motivated sellers. Charter's regional focus suggests it relies on localized reputation and repeat interactions within known referral networks rather than broad auction processes. The firm's deliberate low public profile limits visibility into its specific sourcing channels.

Charter does not publicly disclose its investment structure, and no record of institutional fund closes, limited partners, or SEC-registered fund vehicles is available through public filings. This suggests the firm may operate as an independent sponsor — raising capital on a deal-by-deal basis — or as a closely held operator-investor vehicle funded by principals or a single-family source. In the lower-mid-market healthcare consolidation space, this deal-by-deal model is common and allows for greater flexibility in hold periods and capital deployment pacing.

Charter's hospice-focused portfolio is directly exposed to Medicare reimbursement policy, particularly the per-diem rate structure set by CMS and enforced through Medicare Administrative Contractors. Changes to eligibility criteria, payment caps, or quality reporting requirements can materially affect revenue and margins across the portfolio. Additionally, increased OIG scrutiny of hospice length-of-stay patterns and patient eligibility determinations represents an ongoing operational risk. The 2024 introduction of the Special Focus Program for underperforming hospices adds a new layer of regulatory enforcement.

Charter Healthcare Group is headquartered in Rancho Cucamonga, California, and available evidence points to a primary operational footprint in Southern California and the greater Inland Empire. The firm's strategy appears to favor regional density — building a concentrated network of hospice agencies within a manageable geographic radius — rather than a multi-state or national footprint. This approach supports shared clinical leadership and tighter referral coordination, though the full geographic scope of Charter's portfolio is not publicly enumerated.